Consort Medical PLC Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest, by Ian Nicholson, was filed 12 Aug 2019.
Consort Medical PLC: what insiders have been doing
This page follows insider dealings at Consort Medical PLC as filed with RNS (LSE). No insider at Consort Medical PLC has published a filing in the past twelve months. The most recent one dates from 6 February 2020.
Our records for Consort Medical PLC go back to 2013, with 11 purchases and 3 sales on the open market in total.
These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
- 432,399 sharesExercise of options: Off market Sale of share under offer: London Stock ExchangeISIN GB0000946276FCA-NSM:LSE20200206163125_3486886_20200331164939827_5995-0
- 293,697 sharesExercise of options: Off market Sale of share under offer: London Stock ExchangeISIN GB0000946276FCA-NSM:LSE20200206163125_3486886_20200331164939827_5995-1
- 155,165 sharesExercise of options: Off market Sale of share under offer: London Stock ExchangeISIN GB0000946276FCA-NSM:LSE20200206163125_3486886_20200331164939827_5995-2
- 14 shares@ £10.54790.0% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20191211093201_14344236_20200326185105895_19266-0
- 14 shares@ £10.54790.2% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20191211093201_14344236_20200326185105895_19266-1
- 21 shares@ £7.360.0% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20191111112348_14302817_20200326185148287_22020-0
- 20 shares@ £7.360.2% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20191111112348_14302817_20200326185148287_22020-1
- 164 shares@ £7.4080.1% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20191101070006_14290011_20200326185148836_32421-0
- 7 shares@ £7.40860.1% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20191101070006_14290011_20200326185148836_32421-1
- 36 shares@ £7.40810.5% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20191101070006_14290011_20200326185148836_32421-2
- 20 shares@ £7.29448.6% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20191009101440_14259719_20200326185154548_26986-0
- 21 shares@ £7.293851.1% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20191009101440_14259719_20200326185154548_26986-1
- 20 shares@ £7.73151.4% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20190913090323_14225783_20200326185204416_24361-0
- 19 shares@ £7.731148.9% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20190913090323_14225783_20200326185204416_24361-1
- 69,438 sharesOff market transactionISIN GB0000946276FCA-NSM:LSE20190829120613_14206597_20200326185055315_3003-0
- 67,150 sharesOff market transactionISIN GB0000946276FCA-NSM:LSE20190829120613_14206597_20200326185055315_3003-1
- 25,810 sharesOff market transactionISIN GB0000946276FCA-NSM:LSE20190829120613_14206597_20200326185055315_3003-2
- 46,625 sharesOff market transactionISIN GB0000946276FCA-NSM:LSE20190816110857_14192123_20200326185057267_20340
- 1,350 shares@ £7.36100.0% of flowNEX Trading Equity (NEXT)ISIN GB0000946276FCA-NSM:LSE20190812163007_14185873_20200326185057927_27826Canonical exit: 7 Nov 2019 (T+90)
- 20 shares@ £7.520.0% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20190812095436_14185124_20200326185058006_28632-0
- 20 shares@ £7.520.2% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20190812095436_14185124_20200326185058006_28632-1
- 1,000 shares@ £7.319100.0% of flowLondon Stock Exchange XLONISIN GB0000946276FCA-NSM:LSE20190806070017_14177302_20200326185058977_36516Canonical exit: 31 Oct 2019 (T+90)
- 14,655 sharesOff market transactionISIN GB0000946276FCA-NSM:LSE20190730070023_14167639_20200326185123058_3846
- 3,487 shares@ £7.742.2% of flowOutside of a trading venueISIN GB0000946276FCA-NSM:LSE20190725084415_14162891_20200326185123330_8757-0
- 2,325 shares@ £7.7432.7% of flowOutside of a trading venueISIN GB0000946276FCA-NSM:LSE20190725084415_14162891_20200326185123330_8757-1
25 of 84 declarations
About Consort Medical PLC
Consort Medical PLC is a UK-based company specializing in the design and manufacture of medical devices. It primarily operates in the healthcare sector, providing innovative solutions for respiratory care and drug delivery.
